Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gotlib

Showing results (41-50 of 246) with videos related to

Pageof 25
Sort By:
Best Practice & Research. Clinical Haematology|September 6, 2014
Hereditary erythrocytosis, thrombocytosis and neutrophiliaWan-Jen Hong, Jason Gotlib
Journal of the National Comprehensive Cancer Network : JNCCN|September 25, 2009
Novel biospecific agents for the treatment of myelodysplastic syndromesJason Gotlib, Peter L Greenberg
Clinical Advances in Hematology & Oncology : H&O|July 8, 2021
Diagnosis and management of neutrophilic myeloid neoplasmsMatthew Schwede, Jason Gotlib, William Shomali
American Journal of Hematology|October 3, 2012
Accessory splenules in autoimmune hemolytic anemiaAaron Logan, Caroline Berube, Jason Gotlib
Mayo Clinic Proceedings|January 8, 2010
Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment updateAyalew Tefferi, Jason Gotlib, Animesh Pardanani
Blood|February 28, 2020
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosisAndreas Reiter, Tracy I George, Jason Gotlib
Leukemia & Lymphoma|May 20, 2009
Molecular stratification of patients with normal karyotype acute myeloid leukemia based on initial assessment of FLT3-internal tandem duplication status at first complete remissionBruno C Medeiros, Jason Gotlib, James Zehnder
Blood|July 25, 2022
Avapritinib for advanced systemic mastocytosisJason Gotlib, Andreas Reiter, Daniel J DeAngelo
Therapeutic Advances in Hematology|April 23, 2013
Next-generation sequencing in hematologic malignancies: what will be the dividends?Jason D Merker, Anton Valouev, Jason Gotlib
Current Hematologic Malignancy Reports|October 7, 2017
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid LeukemiaKim-Hien T Dao, Jeffrey W Tyner, Jason Gotlib
Pageof 25

Showing results (41-50 of 246) with videos related to

Sort By:
Pageof 25
Best Practice & Research. Clinical Haematology|September 6, 2014
Hereditary erythrocytosis, thrombocytosis and neutrophiliaWan-Jen Hong, Jason Gotlib
Journal of the National Comprehensive Cancer Network : JNCCN|September 25, 2009
Novel biospecific agents for the treatment of myelodysplastic syndromesJason Gotlib, Peter L Greenberg
Clinical Advances in Hematology & Oncology : H&O|July 8, 2021
Diagnosis and management of neutrophilic myeloid neoplasmsMatthew Schwede, Jason Gotlib, William Shomali
American Journal of Hematology|October 3, 2012
Accessory splenules in autoimmune hemolytic anemiaAaron Logan, Caroline Berube, Jason Gotlib
Mayo Clinic Proceedings|January 8, 2010
Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment updateAyalew Tefferi, Jason Gotlib, Animesh Pardanani
Blood|February 28, 2020
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosisAndreas Reiter, Tracy I George, Jason Gotlib
Leukemia & Lymphoma|May 20, 2009
Molecular stratification of patients with normal karyotype acute myeloid leukemia based on initial assessment of FLT3-internal tandem duplication status at first complete remissionBruno C Medeiros, Jason Gotlib, James Zehnder
Blood|July 25, 2022
Avapritinib for advanced systemic mastocytosisJason Gotlib, Andreas Reiter, Daniel J DeAngelo
Therapeutic Advances in Hematology|April 23, 2013
Next-generation sequencing in hematologic malignancies: what will be the dividends?Jason D Merker, Anton Valouev, Jason Gotlib
Current Hematologic Malignancy Reports|October 7, 2017
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid LeukemiaKim-Hien T Dao, Jeffrey W Tyner, Jason Gotlib
Pageof 25